Symbols

ZEPP

Zepp Health·NYSE

--(--)

ZEPP fundamentals

ZEPP Q4 2025 Earnings

Zepp Health (ZEPP) released its earnings on Mar 16, 2026: revenue was 85.17M (YoY +43.03%), beat estimates; EPS was -0.03 (YoY +78.57%), missed estimates.

Revenue / YoY

85.17M

+43.03%

EPS / YoY

-0.03

+78.57%

Report date

Mar 16, 2026

ZEPP Earnings Call Summary for Q4,2025

Revenue Growth: 43% Q4 YoY, 41.8% full-year, driven by premium products.
Gross Margin: 40.4% (record high), enabled by product mix and pricing.
2026 Outlook: $50-55M Q1 revenue, 30-43% YoY growth, targeting premium segments.
Partnerships: Athlete collaborations enhance brand credibility and ecosystem integration.
Risks: Currency fluctuations, supply chain costs, but strong cash flow management.

Earnings

EPS

Revenue

Revenue & Expenses

ZEPP has released its 2025 Q4 earnings report, with revenue of 85.17M, reflecting a YoY change of 43.03%, and net profit of -10.97M, showing a YoY change of 70.27%. The Sankey diagram below clearly presents ZEPP's revenue sources and cost distribution.

Key Indicators

Zepp Health (ZEPP) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Zepp Health (ZEPP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Zepp Health (ZEPP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Zepp Health (ZEPP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown